Work

The PARADIGM trial: A phase III study comparing sequential therapy (ST) to concurrent chemoradiotherapy (CRT) in locally advanced head and neck cancer (LANHC).

Year: 2012

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2012.30.15_suppl.5501

Authors: Robert I. Haddad, Guilherme Rabinowits, Roy B. Tishler, Douglas Adkins, Fadlo Raja Khuri, Joseph Clark, Jochen H. Lorch, Sewanti Atul Limaye, Lori J. Wirth, Anne O'Neill, Sarah Riley, Marshall R. Posner

Institutions: Harvard University, Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center, Washington University in St. Louis, Emory University, Winship Cancer Institute, Loyola University Medical Center, Massachusetts General Hospital

Language: English

Topic: Head and Neck Cancer Studies

Subfield: Otorhinolaryngology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2204273945

Cites:

Cited by: 44

Related to: 10